BioAtla, Inc. (BCAB): Nasdaq/NYSE listing notice — BioAtla receives Nasdaq notice of non-compliance with minimum bid price rule; 180 days to cure

BioAtla, Inc.

Received Nasdaq notice on Feb 6, 2025 for failing minimum bid price of $1.00 for 30 consecutive business days.
Company has 180 calendar days (until Aug 5, 2025) to regain compliance.
Compliance can be achieved by maintaining $1.00 closing bid for 10 consecutive business days.
Additional 180-day compliance period possible if transferred to Nasdaq Capital Market.
If not cured, common stock subject to delisting; company considering options.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BioAtla, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 6, 2025, BioAtla, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance wi

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

BioAtla, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 6, 2025, BioAtla, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) because the Company has not maintained a minimum closing bid price of the Company’s common stock of at least $1.00 per share for the last 30 consecutive business days. The Notice has no immediate effect on the listing or trading of the Company’s securities. The Company has 180 calendar days from the date of the Notice, or until Aug

View on SEC.gov

Browse all listing & compliance notices →

BioAtla, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-016321

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.